5 research outputs found

    Π˜ΠΠ€Π•ΠšΠ¦Π˜ΠžΠΠΠ«Π• ΠžΠ‘Π›ΠžΠ–ΠΠ•ΠΠ˜Π― ΠŸΠžΠ‘Π›Π• Π Π•ΠšΠžΠΠ‘Π’Π Π£ΠšΠ’Π˜Π’ΠΠ«Π₯ ΠžΠŸΠ•Π ΠΠ’Π˜Π’ΠΠ«Π₯ Π’ΠœΠ•Π¨ΠΠ’Π•Π›Π¬Π‘Π’Π’ Π£ Π‘ΠžΠ›Π¬ΠΠ«Π₯ РАКОМ ΠœΠžΠ›ΠžΠ§ΠΠžΠ™ Π–Π•Π›Π•Π—Π«. ΠžΠŸΠ˜Π‘ΠΠΠ˜Π• ΠšΠ›Π˜ΠΠ˜Π§Π•Π‘ΠšΠžΠ“Πž БЛУЧАЯ

    Get PDF
    Introduction. Currently, there is no global consensus regarding the management of breast cancer patients with implant-associated infections. Some studies clearly recommend their removal and surgical debridement with consecutive antimicrobial treatment, while others prefer long-term antibacterial therapy (at least 1 month) with the effectiveness of such conservative approach of 36–73 %.Case description. A 43-year-old patient suffering from brca1-positive right breast cancer t2n0m0 (invasive carcinoma of non-specific type g3, er – 8, pgr – 0, her-2/neu – 0, ki67 (%) – less than 20 %), underwent radical skin-preserving mastectomy on the right with simultaneous implant reconstruction and preventive subcutaneous mastectomy on the left with simultaneous implant reconstruction. Peri-implant infection in the left breast was observed on the 21st day after surgery.Results. The patient received empirical therapy with cefepim. Microbiological examination of the punctate revealed the causative agent of infection – methicillin-resistant staphylococcus aureus (mrsa) (1Γ—105cfu/ml). Daptomycin 6 mg/kg/day was added to therapy. After 8 weeks, the patient received oral moxifloxacin 400 once daily, for another 3 weeks. A complete response was achieved. The patient has no signs of infection for 3 years.Conclusion. Long-term etiotropic antibacterial therapy with daptomycin followed by oral moxifloxacin resulted in a stable clinical effect.ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ. Π’ настоящСС врСмя Π² ΠΌΠΈΡ€Π΅ Π½Π΅Ρ‚ Π΅Π΄ΠΈΠ½ΠΎΠ³ΠΎ мнСния Π² ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΠΈ Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΈ вСдСния ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ с Ρ€Π°ΠΊΠΎΠΌ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ с ΠΈΠΌΠΏΠ»Π°Π½Ρ‚-ассоциированными инфСкциями. Π’ ΠΎΠ΄Π½ΠΈΡ… исслСдованиях ΠΎΠ΄Π½ΠΎΠ·Π½Π°Ρ‡Π½ΠΎ Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½Ρ‹ ΠΈΡ… ΡƒΠ΄Π°Π»Π΅Π½ΠΈΠ΅ ΠΈ хирургичСская санация c ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅ΠΉ Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠ΅ΠΉ, Π² Π΄Ρ€ΡƒΠ³ΠΈΡ… – отдаСтся ΠΏΡ€Π΅Π΄ΠΏΠΎΡ‡Ρ‚Π΅Π½ΠΈΠ΅ Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ Π°Π½Ρ‚ΠΈΠΌΠΈΠΊΡ€ΠΎΠ±Π½ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ (Π½Π΅ ΠΌΠ΅Π½Π΅Π΅ 1 мСс), ΠΏΡ€ΠΈ этом ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ консСрвативного ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Π° достигаСт 36–73 %.ΠšΠ»ΠΈΠ½ΠΈΡ‡Π΅ΡΠΊΠΈΠΉ случай. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠ΅ 43 Π»Π΅Ρ‚, ΡΡ‚Ρ€Π°Π΄Π°ΡŽΡ‰Π΅ΠΉ BRCa1-ΠΏΠΎΠ»ΠΎΠΆΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ Ρ€Π°ΠΊΠΎΠΌ ΠΏΡ€Π°Π²ΠΎΠΉ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ t2n0M0 (инвазивная ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΠ° нСспСцифичСского Ρ‚ΠΈΠΏΠ° G3, eR – 8, PgR – 0, Her-2/neu – 0, Ki67 (%) – ΠΌΠ΅Π½Π΅Π΅ 20 %), Π±Ρ‹Π»ΠΈ Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½Ρ‹ Ρ€Π°Π΄ΠΈΠΊΠ°Π»ΡŒΠ½Π°Ρ коТСсохранная мастэктомия справа с ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½Ρ‚Π½ΠΎΠΉ рСконструкциСй ΠΈΠΌΠΏΠ»Π°Π½Ρ‚ΠΎΠΌ ΠΈ профилактичСская подкоТная мастэктомия слСва с ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½Ρ‚Π½ΠΎΠΉ рСконструкциСй ΠΈΠΌΠΏΠ»Π°Π½Ρ‚ΠΎΠΌ. Π½Π° 21-Π΅ сут послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ Ρ€Π°Π·Π²ΠΈΠ»Π°ΡΡŒ инфСкция Π² области ΠΈΠΌΠΏΠ»Π°Π½Ρ‚Π° Π»Π΅Π²ΠΎΠΉ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠ΅ эмпиричСски Π±Ρ‹Π»Π° Π½Π°Π·Π½Π°Ρ‡Π΅Π½Π° тСрапия Ρ†Π΅Ρ„Π΅ΠΏΠΈΠΌΠΎΠΌ. ΠŸΡ€ΠΈ микробиологичСском исслСдовании ΠΏΡƒΠ½ΠΊΡ‚Π°Ρ‚Π° Π±Ρ‹Π» выявлСн Π²ΠΎΠ·Π±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ – ΠΌΠ΅Ρ‚ΠΈΡ†ΠΈΠ»Π»ΠΈΠ½-рСзистСнтный золотистый стафилококк (MRSA) Π² количСствС 1Γ—105ΠΊΠžΠ•/ΠΌΠ». ΠΊ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π±Ρ‹Π» Π΄ΠΎΠ±Π°Π²Π»Π΅Π½ Π΄Π°ΠΏΡ‚ΠΎΠΌΠΈΡ†ΠΈΠ½ 6 ΠΌΠ³/ΠΊΠ³/сут. Π§Π΅Ρ€Π΅Π· 8 Π½Π΅Π΄ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠ° Π±Ρ‹Π»Π° ΠΏΠ΅Ρ€Π΅Π²Π΅Π΄Π΅Π½Π° Π½Π° ΠΏΠ΅Ρ€ΠΎΡ€Π°Π»ΡŒΠ½Ρ‹ΠΉ моксифлоксацин 400 ΠΌΠ³ 1 Ρ€Π°Π· Π² сут, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΉ ΠΏΠΎΠ»ΡƒΡ‡Π°Π»Π° Π΅Ρ‰Π΅ 3 Π½Π΅Π΄. Π½Π° Ρ„ΠΎΠ½Π΅ лСчСния Π±Ρ‹Π» ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½ ΠΏΠΎΠ»Π½Ρ‹ΠΉ эффСкт. Π‘ΠΎΠ»ΡŒΠ½Π°Ρ Π±Π΅Π· ΠΏΡ€ΠΈΠ·Π½Π°ΠΊΠΎΠ² ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 3 Π»Π΅Ρ‚.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π”Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ этиотропная Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½Π°Ρ тСрапия с использованиСм Π΄Π°ΠΏΡ‚ΠΎΠΌΠΈΡ†ΠΈΠ½Π° с ΠΏΠ΅Ρ€Π΅Ρ…ΠΎΠ΄ΠΎΠΌ Π½Π° ΠΏΠ΅Ρ€ΠΎΡ€Π°Π»ΡŒΠ½Ρ‹ΠΉ моксифлоксацин ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»Π° ΠΏΠΎΠ»ΡƒΡ‡ΠΈΡ‚ΡŒ стойкий клиничСский эффСкт ΠΈ своСврСмСнно провСсти Π°Π΄ΡŠΡŽΠ²Π°Π½Ρ‚Π½ΠΎΠ΅ ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²ΠΎΠ΅ Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅

    PRIMARY SYNOVIAL CHONDROMATOSIS OF THE SHOULDER (CASE REPORT)

    No full text
    Primary synovial chondromatosis of a shoulder is quite rare in clinical practice. The diagnostics of this pathology has to include the histological examination of intraarticular material to detect the signs of tissue malignant transformation. Currently surgical intervention of this disease involves the removal of intra-articular cartilaginous bodies and local synovectomy of the affected joint by arthroscopic or open methods. The authors describe the clinical, histologic and arthroscopic features of primary synovial chondromatosis of the shoulder in order to assess the possibility of its minimally invasive correction. The clinical example of diagnostics and treatment of patient with this pathology was presented

    LONG-TERM RESULTS OF ARTHROSCOPIC TREATMENT FOR INSTABILITY AT RECURRENT SHOULDER JOINT, CAUSES OF FAILURE

    No full text
    The authors analyse the results of the performance of arthroscopy stitch on the injured capsule with the use of anchor on 46 patients with anterior recurring instability of the shoulder joint within a period of time from 6 months to 4 years. When assessing the results of the given treatment, functional scales, clinical examination methods and radiological methods have been used. The article presents the results of arthroscopy diagnosis of the interior joint damage accompanying the recurring instability ofΒ the shoulder joint. The effectiveness of the conducted operations was 93,5%. The occurrence of postoperative relapses of joint instability (reoccurring dislocations) in 3 patients (6,5%) was caused by the presence of significant damage of bone formations in the shoulder joint – the shoulder-blade joint socket and the shoulder-bone head as well as the reduction of the strength and elasticity of the soft-tissue structures

    ARTHROSCOPY POSSIBILITIES IN TREATMENT OF INJURIES OF THE SHOULDER ROTATOR CUFF

    No full text
    The authors analyzed the results of arthroscopic treatment 58 patients with various injuries of rotator cuff. Follow-up was from 4 months to 3 years (average 18 Β± 5,2 months) after surgery. The quantitative MRI characteristics allowing to define prognostically unfavorable variants of rotator cuff surgery are presented. The authors considered the ways out of such situations including the partial restoration of the rotator cuff structures by arthroscopic method and reverse shoulder arthroplasty
    corecore